Solr Search

th and an Associate Professor of Medicine at Brigham and Women's Hospital at Harvard Medical School.

ed leader in building capital markets in emerging market countries to mobilize private finance for sustainable development.

was the fifth most common cancer in the US. It is also the most expensive cancer to treat and frequently reoccurs.

direction of the

eaders are just beginning to understand the promise of an engaged older population.

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

changed how consumers and businesses transact, interact, and access financial services.

entrepreneurs seeking to address the inefficiencies and lack of customer-centricity in the current ecosystem.

with financial services and products.